TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · no major macro event
ELTX

Elicio Therapeutics Inc.

Healthcare · Biotechnology

1.80$ -2.1% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Income Statement

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Income Statement ELTX
Line item 2012 2013 2018 2019 2020 2021 2022 2023 2024 2025
– -9.8% -38.8% -63.1% +93.7% +883.1% -100.0% – – –
– -13.6% -88.0% +198.9% +60.0% -32.1% -14.3% +10.7% +0.7% -4.2%
– -6.0% +7.1% -90.4% +202.6% +2,449.7% -103.9% – – –
– – +4,568.7% +225.5% +30.5% +25.0% -64.9% +33.0% +48.4% -26.0%
– – – – +7.2% +151.3% -25.4% +111.3% -4.8% +13.1%
– -5.9% +372.8% +116.5% +44.7% +17.8% -65.8% +52.5% +26.7% -16.5%
– – – – – – – – – –
– -2.3% – – – -90.1% +310.3% -70.5% -57.0% +149.0%
– +45.1% -1,255.9% – – – – – – –
– +124.3% – – -89.0% +9,701.4% +310.3% – – –
– +105.7% -3,267.3% – – – – – – –
– -96.8% -23,029.3% – – – – – – –

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?